A Study of TAVO412 in Patients with Cancer (TAVO412)
Clinical trial NCT06761651 · RECRUITING
Trial details
- NCT number
- NCT06761651
- Sponsor
- Tavotek Biotherapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2026-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.